ESC Premium Access

Association of CYP2C19*2 and PEAR1 gene variant with platelet reactivity and clinical outcomes in patients undergoing stenting and treated with aspirin and clopidogrel

Congress Presentation

About the speaker

Doctor Ke Xu

Shanghai Chest Hospital, Shanghai (China)
0 follower

5 more presentations in this session

HDL-cholesterol dysfunction and inflammation in patients with genotypes associated with different responses to dalcetrapib

Speaker: Doctor A. Franci (Sao Paulo, BR)


CYP2C19 genotyping as complementary tool for guidance of early de-escalation of antiplatelet treatment in acute coronary syndrome patients

Speaker: Doctor L. Gross (Munich, DE)


Prasugrel or clopidogrel in non-st-elevation acute coronary syndrome with CYP2C19 genetic variants undergoing percutaneous coronary intervention

Speaker: Doctor S. Kim (Busan, KR)


Comparison of three different platelet function tests in patients on P2Y12 inhibitors in correlation to genetic background.

Speaker: Mrs R. Olie (Maastricht, NL)


Genetic influence on warfarin dose determination

Speaker: Doctor J. Li (Busan, KR)


Access the full session

Poster Session 6 - Pharmacogenetics - New sights on the horizon

Speakers: Doctor K. Xu, Doctor A. Franci, Doctor L. Gross, Doctor S. Kim, Mrs R. Olie...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb